Followers | 130 |
Posts | 8869 |
Boards Moderated | 0 |
Alias Born | 05/02/2012 |
![](https://investorshub.advfn.com/uicon/340259.png?cb=1654954331)
Tuesday, September 07, 2021 4:27:33 PM
Recent ENVB News
- Aries Science & Technology and Enveric Biosciences Announce Issuance of Key US Patent Under Aries’ License for Treatment of Radiation Dermatitis and Other Conditions • Business Wire • 08/13/2024 12:00:00 PM
- Enveric Biosciences Reports Second Quarter 2024 Financial and Corporate Results • Business Wire • 08/12/2024 09:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/12/2024 09:13:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/12/2024 09:05:46 PM
- Enveric Biosciences Announces Preclinical Results Confirming Potential of EB-003 to be Dosed Orally • Business Wire • 07/25/2024 12:00:00 PM
- Aries Science & Technology and Enveric Biosciences Announce Licensing Agreement • Business Wire • 07/15/2024 01:02:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/15/2024 12:00:39 PM
- Enveric Biosciences Announces Patent Granted for Drug Candidate • Business Wire • 07/10/2024 12:00:00 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 07/08/2024 09:10:29 PM
- Enveric Biosciences Provides Strategic Outlook and Pipeline Update, Elevating EB-003 to Lead Development Candidate • Business Wire • 06/25/2024 12:00:00 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 06/03/2024 10:58:26 PM
- Enveric Biosciences to Participate in BIO International Convention 2024 • Business Wire • 05/30/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/29/2024 08:15:22 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/23/2024 12:00:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/17/2024 09:25:22 PM
- Enveric Biosciences Reports First Quarter 2024 Financial and Corporate Results • Business Wire • 05/15/2024 10:00:00 AM
- Enveric Biosciences Signs $66.5 Million Non-Binding Term Sheet with MindBio Therapeutics to Out-License Novel Psilocin Prodrug Candidate for Mental Health Disorders • Business Wire • 05/14/2024 12:00:00 PM
- Enveric Biosciences Announces Signing of Non-Binding Term Sheet with Undisclosed Licensee for Exclusive License to Patented Methods of Treating Breast and Other Cancers Using Cannabinoids • Business Wire • 05/08/2024 11:00:00 AM
- Enveric Biosciences Reports Financial Results and Provides Corporate Update for Fourth Quarter and Fiscal Year Ended 2023 • Business Wire • 03/26/2024 11:00:00 AM
- Enveric Biosciences Signs Non-Binding Term Sheets to Pursue the Exclusive Out-Licensing of New Chemical Entities for Pharmaceutical and Non-Pharmaceutical Applications in Joint Disease • Business Wire • 03/19/2024 11:00:00 AM
- Enveric Biosciences Announces New Patent Issuances Protecting Multiple Assets Covered by Non-Binding Term Sheets • Business Wire • 03/12/2024 11:00:00 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 03/11/2024 04:35:33 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/11/2024 12:00:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/29/2024 12:00:24 PM
HealthLynked Corp. Announces Second Quarter and First Half 2024 Results: Continued Cost Reductions Set the Stage for Strategic Shift to App-Based Technology Services • HLYK • Aug 16, 2024 8:00 AM
PickleJar Announces Official Name Change and New Ticker Symbol • NREG • Aug 15, 2024 2:23 PM
VAYK's Q2 Profit Added to Accumulated Net Profit of Over $2.2 Million In 18 Months • VAYK • Aug 15, 2024 9:07 AM
Swifty Global Reports Strong Q2 Performance and Prepares for Major Exchange Uplisting • DRCR • Aug 15, 2024 9:04 AM
Mayback's Global Entertainment Signs Global Distribution Agreement with Children's Media Studio • AHRO • Aug 15, 2024 8:45 AM
POET Technologies Reports Second Quarter 2024 Financial Results • POET • Aug 15, 2024 8:04 AM